FTK FLOTEK INDUSTRIES INC/CN/
Miscellaneous Chemical Products · NYSE · SEC CIK 928054 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY59.3%
TTM net income YoY-3.1%
TTM EPS YoY-15.2%
Revenue 3-yr CAGR21.9%
Net income 3-yr CAGR105.2%
Margins
Gross margin23.3%
Operating margin13.2%
Net margin8.8%
FCF margin—
EBITDA margin14.0%
Returns
ROE24.4%
ROA11.8%
ROIC (approx.)26.2%
Asset turnover1.34x
Leverage & solvency
Liabilities / assets53.9%
Debt / equity0.00x
Current ratio2.30x
Interest coverage8.45x
Cash quality & payout
Operating cash flow / net income-0.34x
Accruals ratio15.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $237.26M | $187.03M | $188.06M | $136.09M | $43.27M |
| Cost of revenue | $177.43M | $147.64M | $163.79M | $142.79M | $40.01M |
| Gross profit | $59.83M | $39.39M | $24.26M | -$6.70M | $3.26M |
| R&D expense | $1.82M | $1.71M | $2.49M | $4.44M | $5.54M |
| SG&A expense | $28.05M | $24.71M | $27.83M | $27.12M | $20.17M |
| Operating income | $23.24M | $12.20M | $23.22M | -$35.42M | -$31.46M |
| Interest expense | $3.94M | $1.09M | $2.86M | $7.05M | $78,000 |
| Pretax income | $19.66M | $11.15M | $24.86M | -$42.33M | -$30.57M |
| Income tax | -$10.87M | $649,000 | $149,000 | -$22,000 | -$40,000 |
| Net income | $30.53M | $10.50M | $24.71M | -$42.30M | -$30.53M |
| EBITDA | $25.08M | $13.09M | $23.96M | -$34.69M | -$30.45M |
| EPS (basic) | 0.90 | 0.36 | 1.00 | -3.41 | -0.42 |
| EPS (diluted) | 0.84 | 0.34 | -0.10 | -3.41 | -0.42 |
| Weighted avg. shares (diluted) | 36.16M | 30.89M | 28.38M | 12.40M | 73.36M |
| Balance sheet | |||||
| Cash & equivalents | $5.73M | $4.40M | $5.85M | $12.29M | $11.53M |
| Receivables | — | — | — | $19.14M | $12.00M |
| Inventory | $10.63M | $13.30M | $12.84M | $15.72M | $9.45M |
| Current assets | $110.78M | $96.46M | $76.45M | $80.07M | $42.60M |
| PP&E, net | $20.34M | $6.18M | $5.13M | $4.83M | $5.30M |
| Goodwill | — | — | — | — | $0 |
| Total assets | $220.05M | $170.80M | $157.51M | $164.81M | $50.24M |
| Current liabilities | $61.58M | $50.37M | $47.78M | $151.37M | $18.78M |
| Short-term debt | — | — | — | — | $1.44M |
| Long-term debt | $40.00M | $0 | $60,000 | $2.74M | $3.35M |
| Total debt | $40.00M | $0 | $60,000 | $2.74M | $4.79M |
| Total liabilities | $106.99M | $56.90M | $55.55M | $162.21M | $30.05M |
| Shareholders' equity | $113.06M | $113.90M | $101.96M | $2.60M | $20.19M |
| Net debt | $34.27M | -$4.40M | -$5.79M | -$9.55M | -$6.75M |
| Shares outstanding | 30.13M | 29.83M | 29.66M | 12.96M | 73.46M |
| Cash flow statement | |||||
| Operating cash flow | $7.20M | $3.36M | -$11.30M | -$44.63M | -$25.84M |
| Capital expenditure | — | — | — | $421,000 | $39,000 |
| Free cash flow | — | — | — | -$45.05M | -$25.88M |
| Investing cash flow | -$1.98M | -$1.82M | -$1.01M | $5.33M | $112,000 |
| Financing cash flow | -$3.74M | -$3.12M | $5.93M | $38.27M | -$372,000 |
| Depreciation & amortization | $1.84M | $891,000 | $734,000 | $734,000 | $1.01M |
| Stock-based compensation | $2.30M | $1.37M | -$254,000 | $3.33M | $3.76M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.